Ocean Pointe Healthcare Center cut Resident 1's daily Donepezil dose from 15 milligrams to 10 milligrams on December 12, 2024. The medication treats dementia symptoms. The facility's own policy requires notifying residents' legal representatives of medical changes, but staff never contacted the person holding power of attorney.
The resident had severe cognitive impairment and couldn't understand medical decisions independently, according to assessment records. They required substantial assistance with basic activities like bathing, dressing and toileting.
Resident 1 was admitted with multiple conditions including muscle weakness, difficulty swallowing, dementia, high cholesterol and hypothyroidism. Medical records showed a designated responsible party held power of attorney to handle the resident's affairs.
The original medication order called for one 5-milligram Donepezil tablet in the morning and two 5-milligram tablets at bedtime, totaling 15 milligrams daily. On December 12, a physician reduced the dose to 10 milligrams per day, but progress notes contained no indication that staff contacted the family.
Ocean Pointe's Director of Staff Development confirmed during the inspection that nursing and physician notes from December 12 through January 7 showed no communication with the responsible party about the medication change.
"The family member would be disappointed if they were not made aware and any changes should be reported to the responsible party," the director told inspectors. "It is their right to know."
The facility's own resident rights policy, revised in January 2025, explicitly guarantees residents the right to appoint a legal representative and be notified of medical conditions and changes. The policy also ensures residents can be informed of and participate in care planning and treatment.
Federal regulations require nursing homes to keep residents and their representatives fully informed about health status, care and treatments. When residents cannot understand their medical situation due to cognitive impairment, facilities must communicate with designated family members or legal representatives.
The medication change represented a significant reduction in the dementia treatment. Donepezil is commonly prescribed to help manage symptoms of Alzheimer's disease and other forms of dementia by improving cognitive function and daily living abilities.
Inspectors classified the violation as having minimal harm or potential for actual harm. However, the failure to communicate medical changes can undermine family members' ability to advocate for appropriate care and understand their loved one's condition.
The resident required setup assistance for eating and oral hygiene, plus moderate to substantial help with personal care tasks. Such extensive care needs make family involvement in medical decisions particularly important for ensuring appropriate treatment.
Ocean Pointe's violation occurred despite having written policies that clearly outlined requirements for family notification. The gap between policy and practice left a vulnerable resident's family uninformed about a substantial change in dementia treatment for nearly a month before inspectors discovered the oversight.
The facility must submit a plan of correction addressing how it will ensure responsible parties receive timely notification of medical changes going forward.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Ocean Pointe Healthcare Center from 2025-11-13 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Ocean Pointe Healthcare Center
- Browse all CA nursing home inspections